Bodisen Biotech (FRA:DZ9) ROCE % : -27.14% (As of Jun. 2013)

View and export this data going back to . Start your Free Trial

What is Bodisen Biotech ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Bodisen Biotech's annualized ROCE % for the quarter that ended in Jun. 2013 was -27.14%.

Bodisen Biotech ROCE % Historical Data

The historical data trend for Bodisen Biotech's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bodisen Biotech ROCE % Chart

Bodisen Biotech Annual Data

Trend

Dec03

Dec04

Dec05

Dec06

Dec07

Dec08

Dec09

Dec10

Dec11

Dec12

ROCE %

Get a 7-Day Free Trial

-13.43

-1.60

-9.65

-5.77

-60.32

Bodisen Biotech Quarterly Data
	Jun08	Sep08	Dec08	Mar09	Jun09	Sep09	Dec09	Mar10	Jun10	Sep10	Dec10	Mar11	Jun11	Sep11	Dec11	Mar12	Jun12	Sep12	Dec12	Jun13
ROCE %	Get a 7-Day Free Trial															-11.32	-13.00	-2.33	-214.97	-27.14

Bodisen Biotech ROCE % Calculation

Bodisen Biotech's annualized ROCE % for the fiscal year that ended in Dec. 2012 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2012 )		(A: Dec. 2011 )		(A: Dec. 2012 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2012 )		(A: Dec. 2011 )		(A: Dec. 2012 )
	=	-12.409	/	( ( (28.07 - 2.095)	+	(17.294 - 2.125) )	/ 2 )
	=	-12.409	/	( (25.975	+	15.169)	/ 2 )
	=	-12.409	/	20.572
	=	-60.32 %

Bodisen Biotech's ROCE % of for the quarter that ended in Jun. 2013 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Jun. 2013 )		(Q: Dec. 2012 )		(Q: Jun. 2013 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Jun. 2013 )		(Q: Dec. 2012 )		(Q: Jun. 2013 )
	=	-3.948	/	( ( (17.294 - 2.125)	+	(14.748 - 0.819) )	/ 2 )
	=	-3.948	/	( ( 15.169	+	13.929 )	/ 2 )
	=	-3.948	/	14.549
	=	-27.14 %

(1) Note: The EBIT data used here is four times the quarterly (Jun. 2013) EBIT data.

Bodisen Biotech (FRA:DZ9) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Bodisen Biotech ROCE % Related Terms

Thank you for viewing the detailed overview of Bodisen Biotech's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Bodisen Biotech Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Basic Materials » Agriculture » Bodisen Biotech Inc (FRA:DZ9) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

http://www.bodisen.com

Bodisen Biotech Inc develops, manufactures and sells organic fertilizers, liquid fertilizers, pesticides and insecticides in China.

Bodisen Biotech Headlines

No Headlines